105 related articles for article (PubMed ID: 7902690)
1. CD4 counts as surrogate markers for progression to AIDS.
Harris PJ
Ann Intern Med; 1994 Jan; 120(1):88. PubMed ID: 7902690
[No Abstract] [Full Text] [Related]
2. CD4 counts as surrogate markers for progression to AIDS.
Hirschel B
Ann Intern Med; 1994 Jan; 120(1):87; author reply 88. PubMed ID: 7902687
[No Abstract] [Full Text] [Related]
3. CD4 counts as surrogate markers for progression to AIDS.
Phillips AN; Sabin CA
Ann Intern Med; 1994 Jan; 120(1):87-8. PubMed ID: 7902689
[No Abstract] [Full Text] [Related]
4. [Another AIDS drug. Azidothymidine--dideoxycytidine].
Moosmann EB
Fortschr Med; 1992 Jun; 110(18):28-30. PubMed ID: 1353746
[No Abstract] [Full Text] [Related]
5. Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials.
Lin DY; Fischl MA; Schoenfeld DA
Stat Med; 1993 May; 12(9):835-42. PubMed ID: 8101011
[TBL] [Abstract][Full Text] [Related]
6. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine.
Choi S; Lagakos SW; Schooley RT; Volberding PA
Ann Intern Med; 1993 May; 118(9):674-80. PubMed ID: 8096373
[TBL] [Abstract][Full Text] [Related]
7. The utility of large, simple trials in the evaluation of AIDS treatment strategies.
Ellenberg SS; Foulkes MA
Stat Med; 1994 Mar 15-Apr 15; 13(5-7):405-15. PubMed ID: 7912842
[No Abstract] [Full Text] [Related]
8. Didanosine therapy in patients intolerant of or failing zidovudine therapy.
Rathbun RC; Martin ES
Ann Pharmacother; 1992 Nov; 26(11):1347-51. PubMed ID: 1362093
[TBL] [Abstract][Full Text] [Related]
9. Lymphocytes' intrinsic lymphoproliferative capacity in patients with AIDS treated with zidovudine.
Gerding MN; Schuurman HJ; Bast BJ; Borleffs JC
AIDS; 1989 Oct; 3(10):671-3. PubMed ID: 2574585
[No Abstract] [Full Text] [Related]
10. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
[TBL] [Abstract][Full Text] [Related]
11. [New, in Austria registered specialty drugs. Hivid (2',3'-dideoxycytidine; ddC)].
Töglhofer W
Wien Klin Wochenschr; 1992; 104(12):363-7. PubMed ID: 1353278
[No Abstract] [Full Text] [Related]
12. Surrogate markers in AIDS: where are we? Where are we going?
Lagakos SW; Hoth DF
Ann Intern Med; 1992 Apr; 116(7):599-601. PubMed ID: 1347443
[No Abstract] [Full Text] [Related]
13. AIDS.
N Z Med J; 1992 Sep; 105(941):363. PubMed ID: 1359486
[No Abstract] [Full Text] [Related]
14. Evolution of zidovudine dosing.
Stoukides CA; Cichocki TJ
Ann Pharmacother; 1992 Jun; 26(6):784-5. PubMed ID: 1351766
[No Abstract] [Full Text] [Related]
15. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
[TBL] [Abstract][Full Text] [Related]
16. [Pentoxifylline in the treatment of AIDS].
Ruiz-Argüelles GJ; Lobato-Mendizábal E; Ruiz-Argüelles A; Lagunes-Yannelli B
Rev Invest Clin; 1992; 44(2):285-6. PubMed ID: 1359620
[No Abstract] [Full Text] [Related]
17. Bleak news from the AIDS front.
Berger PB
CMAJ; 1993 Oct; 149(7):1016-8. PubMed ID: 8104677
[No Abstract] [Full Text] [Related]
18. Population-based estimates of zidovudine and aerosol pentamidine use in San Francisco: 1987-1989.
Lang W; Osmond D; Samuel M; Moss A; Schrager L; Winkelstein W
J Acquir Immune Defic Syndr (1988); 1991; 4(7):713-6. PubMed ID: 1675679
[TBL] [Abstract][Full Text] [Related]
19. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
[TBL] [Abstract][Full Text] [Related]
20. Long-term zidovudine therapy in patients with AIDS and symptomatic and asymptomatic HIV infection.
Ebert S; Gockel K; Horowitz S; Weber P; Vogelman B; Graziano F
Wis Med J; 1991 Apr; 90(4):161-5. PubMed ID: 1675028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
